Skip to content

SCHEDULE 13G/AAccepted Mar 30, 5:31 PM ET

Protalix BioTherapeutics, Inc. SCHEDULE 13G/A

MAK Capital Fund LP

Accepted (ET)

5:31 PM

Mar 30, 2026

Filed

Mar 30, 2026

Documents

2

Size

12.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.